Omniome IPO

Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

Omniome Funding Rounds and IPO Valuation

Date	Funding Round	Funding Raised	Price per Share	IPO Valuation
1/9/2020	Series C	$60MM raised	$XXX.XX	$XXX.XX
7/30/2018	Series B-1 and B-2	$60.5MM raised	$XXX.XX	$XXX.XX
1/1/2016	Series A-1 and A-2	$32.79MM raised	$XXX.XX	$XXX.XX

Based on primary financings

Omniome has raised $153.29MM to date.

Omniome was founded in 2013.

Updated on: Jun 12, 2022